The NYT is reporting that, because mainly of allegations made by Sen. Charles Grassley (R-IA), a medical publishing company plans to investigate an article “improperly” ghostwritten by pharma giant Wyeth to promote its patented estrogen, Prempro. Medical ghostwriting is not a new practice. It’s merely just another promotional tool in marketing a pharma company’s product, end user beware. The problem arises, however, when the ugly spectre of misrepresentation occurs. Intentional or apparent? | LINK

Related Posts Within Doctor Pundit:

1. Medical Student Organization Applauds Pharma’s Latest Actions On 1/1/09, Pharma instituted a voluntary ban on all gifts...
2. Medical Student Org Publicizes Medical Schools’ Pharma Policies In a way, the “predation” of pharma companies on medical...
3. Iowa Senator Continues Investigation into Medical Ghostwriting To Senator Charles Grassley (R-IA) ghostwriting and plagiarism fall within...
4. US Settles Suit against Pharma Manufacturer over Vitamin Claims Kinda reminds me of the ol’ snake oil days. Bayer...
5. Court: E-Cigarettes Should Be Treated Like Tobacco A new way for some to curb the addiction to...